AF
SNDX icon

Allworth Financial’s Syndax Pharmaceuticals SNDX Stock Holding History

Allworth Financial’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.4K Buy
1,686
+557
+49% +$12.1K ﹤0.01% 2504
2025
Q4 		$23.7K Buy
1,129
+384
+52% +$6.7K ﹤0.01% 2693
2025
Q3 		$11.5K Buy
745
+505
+210% +$6.61K ﹤0.01% 3061
2025
Q2 		$2.25K Buy
240
+206
+606% +$2.27K ﹤0.01% 3651
2025
Q1 		$453 Sell
34
-125
-79% -$1.76K ﹤0.01% 3706
2024
Q4 		$2.23K Sell
159
-195
-55% -$3.34K ﹤0.01% 3115
2024
Q3 		$6.82K Hold
354
– – ﹤0.01% 2433
2024
Q2 		$8.17K Hold
354
– – ﹤0.01% 2311
2024
Q1 		$8.43K Sell
354
-10
-3% -$223 ﹤0.01% 2177
2023
Q4 		$7.87K Buy
364
+355
+3,944% +$5.46K ﹤0.01% 2083
2023
Q3 		$131 Sell
9
-18
-67% -$340 ﹤0.01% 3295
2023
Q2 		$566 Hold
27
– – ﹤0.01% 2872
2023
Q1 		$571 Sell
27
-39
-59% -$970 ﹤0.01% 2818
2022
Q4 		$1.68K Buy
66
+31
+89% +$723 ﹤0.01% 2303
2022
Q3 		$1K Buy
+35
New +$785 ﹤0.01% 2499

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Allworth Financial's SNDX Position: Q1 2026 in Review

Allworth Financial increased its Syndax Pharmaceuticals (SNDX) stake by 49% in Q1 2026, buying an estimated $12.1K and bringing the position to 1,686 shares worth $39.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2504.

Allworth Financial first reported a position in SNDX in Q3 2022 and has held it in 15 quarters since. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Allworth Financial held 1,686 shares of Syndax Pharmaceuticals worth $39.4K as of Q1 2026.
  • Allworth Financial bought 557 Syndax Pharmaceuticals shares in Q1 2026, an estimated $12.1K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #2504 holding.
  • Allworth Financial first reported a position in Syndax Pharmaceuticals in Q3 2022 and has held it in 15 quarters since.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.